苄噻嗪
| 中文名称 | 苄噻嗪 |
|---|---|
| 中文同义词 | 苄硫醚氯噻嗪;苄硫噻嗪;苄噻嗪;苄噻嗪杂质;苯并噻嗪;苄噻嗪 标准品;苄噻嗪BENZTHIAZIDE;3-((苄硫基)甲基)-6-氯-2H-苯并[E][1,2,4]噻二嗪-7-磺酰胺1,1-二氧化物 |
| 英文名称 | BENZTHIAZIDE |
| 英文同义词 | 6-Chloro-3-[[(phenylMethyl)thio]Methyl]-2H-1,2,4-benzothiadiazine-7-sulfonaMide 1,1-Dioxide;((benzylthio)methyl)-3chloro-6dioxyde-1,1sulfonamide-7benzothiadiazine-1,2,;-1,-dioxide;2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3-((benzylthio)methyl)-6-chloro-, 1,1-dioxide;2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(((phenylmethyl)thio)methyl)-, dioxide;2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-[[(phenylmethyl)thio]methyl]-, 1,1-dioxide;2h-1,2,4-benzothiadiazine-7-sulfonamide,3-((benzylthio)menthyl)-6-chloro-,1,1;2h-1,2,4-benzothiadiazine-7-sulfonamide,6-chloro-3-(((phenylmethyl)thio)methyl |
| CAS号 | 91-33-8 |
| 分子式 | C15H14ClN3O4S3 |
| 分子量 | 431.94 |
| EINECS号 | 202-061-0 |
| 相关类别 | 小分子抑制剂;利尿药物;Aromatics;Heterocycles;Building Blocks;Chemical Synthesis;Heterocyclic Building Blocks;Others;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;AQUATAG;Heterocyclic Compounds;S-Containing |
| Mol文件 | 91-33-8.mol |
| 结构式 | ![]() |
苄噻嗪 性质
| 熔点 | 231-232° (U.S. patent); mp 238-239° (P'an) |
|---|---|
| 沸点 | 680.6±65.0 °C(Predicted) |
| 密度 | 1.4176 (rough estimate) |
| 折射率 | 1.6100 (estimate) |
| 储存条件 | Refrigerator |
| 溶解度 | 可溶于DMSO(少许)、甲醇(少许) |
| 形态 | 固体 |
| 酸度系数(pKa) | 9.57±0.20(Predicted) |
| 颜色 | 白色至类白色 |
| 水溶解性 | 2.8mg/L(room temperature) |
| InChI | 1S/C15H14ClN3O4S3/c16-11-6-12-14(7-13(11)25(17,20)21)26(22,23)19-15(18-12)9-24-8-10-4-2-1-3-5-10/h1-7H,8-9H2,(H,18,19)(H2,17,20,21) |
| InChIKey | NDTSRXAMMQDVSW-UHFFFAOYSA-N |
| SMILES | NS(=O)(=O)c1cc2c(NC(CSCc3ccccc3)=NS2(=O)=O)cc1Cl |
| EPA化学物质信息 | 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-[[(phenylmethyl)thio]methyl]-, 1,1-dioxide (91-33-8) |
Ki: 8.0 nM (CA9), 8.8 nM (CA2), 10 nM (CA1)
Benzthiazide (0.4, 2, 10 μM) suppresses proliferation of cancer cell under hypoxic conditions in a dose-dependent manner
.
Benzthiazide is an inhibitor of carbonic anhydrase 9 (CA9), with K
i
s of 8.0, 8.8 and 10 nM for CA9, CA2 and CA1, respectively.
Benzthiazide (1, 1.5 mg/100 g BW) causes a marked decrease in urinary calcium excretion and the dissociation of calcium and sodium excretion in hyperprolactinemic rats.
安全信息
| 危险品标志 | Xn |
|---|---|
| 危险类别码 | 42/43 |
| 安全说明 | 26-36 |
| WGK Germany | 2 |
| RTECS号 | DK8400000 |
| 存储类别 | 11 - 可燃固体 |
| 危险性类别 | 呼吸道致敏物 类别1 皮肤致敏物 类别1 |
| 毒害物质数据 | 91-33-8(Hazardous Substances Data) |
| 毒性 | LD50 in mice, rats (mg/kg): >5000, >10000 orally; 410, 422 i.v. (P'an) |
| 提供商 | 语言 |
|---|---|
|
英文
|
